Gujarat Terce Laboratories Re-Appoints Aalap Prajapati as MD & CEO
Gujarat Terce Laboratories Ltd 路 Change in Management 路 21 Aug 2026, 9:42 pm
Gujarat Terce Laboratories Re-Appoints Aalap Prajapati as MD & CEO Gujarat Terce Laboratories has re-appointed Mr. Aalap Prajapati as Managing Director & CEO for a three-year term, effective from 28 Oct'26 to 27 Oct'29. The approval was granted at the 41st AGM on 21 Aug'26. Mr. Prajapati has over 15 years of experience in the pharmaceutical sector, specializing in strategy, operations, and business development. He is the son of Mr. Natwarbhai Prajapati, the company's Whole-Time Director. This move signals leadership continuity and a continued focus on operational efficiency and growth initiatives.
Original exchange filing (PDF)
More announcements from Gujarat Terce Laboratories Ltd
- Detailed disclosure is attached. 路 05 Nov 2026
- Detailed disclosure is attached. 路 05 Nov 2026
- In compliance with Regulation 30 read with Schedule III, Regulation 33 and other applicable provisions of the SEBI Listing Regulations, the Board of Directors of Gujarat Terce Laboratories .... 路 05 Nov 2026
- Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Standalone .... 路 05 Nov 2026
- Detailed disclosure is attached 路 21 Aug 2026
- Detailed disclosure is attached. 路 21 Aug 2026
- Corrigendum/Revised intimation regarding Re-appointment of Managing Director & Chief Executive Officer of the Company- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) .... 路 21 Aug 2026
- Detailed disclosure is attached. 路 07 Aug 2026
